0000899243-18-006476.txt : 20180306
0000899243-18-006476.hdr.sgml : 20180306
20180306161207
ACCESSION NUMBER: 0000899243-18-006476
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180302
FILED AS OF DATE: 20180306
DATE AS OF CHANGE: 20180306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Molineaux Susan
CENTRAL INDEX KEY: 0001553389
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36644
FILM NUMBER: 18669999
MAIL ADDRESS:
STREET 1: C/O CALITHERA BIOSCIENCES, INC.
STREET 2: 343 OYSTER POINT BLVD., SUITE 200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Calithera Biosciences, Inc.
CENTRAL INDEX KEY: 0001496671
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 272366329
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 343 OYSTER POINT BLVD #200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-870-1000
MAIL ADDRESS:
STREET 1: 343 OYSTER POINT BLVD #200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-02
0
0001496671
Calithera Biosciences, Inc.
CALA
0001553389
Molineaux Susan
C/O CALITHERA BIOSCIENCES, INC.
343 OYSTER POINT BLVD. #200
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
PRESIDENT AND CEO
Common Stock
2018-03-02
4
M
0
26992
2.64
A
44860
D
Common Stock
349190
I
By Trust
Common Stock
21000
I
By Spouse
Employee Stock Option (Right to Buy)
2.64
2018-03-02
4
M
0
26992
0.00
D
2023-12-16
Common Stock
26992
9729
D
Employee Stock Option (Right to Buy)
2.64
2018-03-02
4
M
0
6798
0.00
D
2023-12-16
Common Stock
6798
0
I
By Spouse
Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on December 8, 2017.
Shares are held by the Molineaux Family Trust, of which the Reporting Person is a Trustee.
1/48 of the Option vests in equal monthly installments one month from 12/17/2013. The option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.
/s/ Susan M. Molineaux
2018-03-06